Inventor · disambiguated record
Winfried Wels
Also filed as: WELS WINFRIED · WELS WINFRIED S · WELS WINFRIED STEPHAN
15 granted patents·5 pending applications·2,152 citations·filing 1994–2022
95Inventor score
Files withCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS8BAYLOR COLLEGE MEDICINE1CIBA GEIGY CORP1G2M CANCER DRUGS AG1NOVARTIS AG1
Top patents by PatentIndex Score
20 records- 0195US5571894ARecombinant antibodies specific for a growth factor receptorCIBA GEIGY CORP·Filed 1994·Granted Nov 5, 1996·1.7k cites·19 claims
- 0292US9487800B2Interleukin 15 as selectable marker for gene transfer in lymphocytesSCHONFELD KURT·Filed 2011·Granted Nov 8, 2016·41 cites·6 claims
- 0391US9815908B2Chimeric antigen receptors with an optimized hinge regionCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG-SPEYER-HAUS·Filed 2015·Granted Nov 14, 2017·11 cites·7 claims
- 0491US9212229B2Chimeric antigen receptors with an optimized hinge regionSCHÖNFELD KURT·Filed 2011·Granted Dec 15, 2015·32 cites·14 claims
- 0588US10351612B2Interleukin 15 as selectable marker for gene transfer in lymphocytesCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2016·Granted Jul 16, 2019·5 cites·7 claims
- 0688US8530637B2Optimized DNA sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteinsWELS WINFRIED S·Filed 2011·Granted Sep 10, 2013·16 cites·23 claims
- 0788US7887801B2Optimized DNA and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteinsTOPOTARGET GERMANY AG·Filed 2008·Granted Feb 15, 2011·19 cites·22 claims
- 0888US5939531ARecombinant antibodies specific for a growth factor receptorNOVARTIS AG·Filed 1995·Granted Aug 17, 1999·100 cites·6 claims
- 0987US6129915AEpidermal growth factor receptor antibodiesSCHERING AG·Filed 1999·Granted Oct 10, 2000·64 cites·8 claims
- 1086US5942602AGrowth factor receptor antibodiesSCHERING AKTIENGESSELLSCHAFT·Filed 1997·Granted Aug 24, 1999·90 cites·25 claims
- 1184US10556969B2Chimeric antigen receptors with an optimized hinge regionCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2017·Granted Feb 11, 2020·3 cites·8 claims
- 1280US9920132B2Car-expressing NK-92 cells as cell therapeutic agentsCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2017·Granted Mar 20, 2018·4 cites·15 claims
- 1356US6498233B1Nucleic acid transfer systemWELS WINFRIED·Filed 1997·Granted Dec 24, 2002·22 cites·3 claims
- 1456US2024174768A1Bispecific antibodies enhancing cell mediated immune responsesCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2022·Application pending·0 cites
- 1550US2018282427A1Car-expressing nk-92 cells as cell therapeutic agentsCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2018·Application pending·0 cites
- 1647US10550197B2CAR-expressing NK-92 cells as cell therapeutic agentsCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2015·Granted Feb 4, 2020·0 cites·11 claims
- 1744US12023353B2Methods and compounds for improved immune cell therapyCHEMOTHERAPEUTISCHES FORSCHUNGSINSTITUT GEORG SPEYER HAUS·Filed 2018·Granted Jul 2, 2024·0 cites·10 claims
- 1835US2005038113A1Valproic acid and derivatives for the combinatorial therapeutic treatment of human cancers and for the treatment of tumor metastasis and minimal residual diseaseG2M CANCER DRUGS AG·Filed 2002·Application pending·0 cites
- 1933US2018079824A1HER2/ErbB2 Chimeric Antigen ReceptorBAYLOR COLLEGE MEDICINE·Filed 2016·Application pending·0 cites
- 2029US2002086012A1Costimulation of t-cell proliferation by a chimeric bispecific costimulatory proteinFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Winfried Wels files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →